Small molecules modulating biogenesis or processing of microRNAs with therapeutic potentials

Current Medicinal Chemistry

Volumn 20, Issue 29, 2013, Pages 3604-3612

  Li, J ^a   Zhang, W ^a   Zhou, M ^a   Kooger, R ^a   Zhang, Y ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Activator; Inhibitor; MiRNA; Small molecules; Specificity; Therapeutics.

Indexed keywords

AZOBENZENE DERIVATIVE; ENOXACIN; EXPORTIN 5; LUCIFERASE; MICRORNA; MICRORNA 122; MICRORNA 21; RNA POLYMERASE II; STREPTOMYCIN;

3' UNTRANSLATED REGION; ARTICLE; BIOGENESIS; CANCER INHIBITION; CHEMICAL STRUCTURE; DRUG TARGETING; GENE EXPRESSION; GENE REPRESSION; GLIOBLASTOMA; HIGH THROUGHPUT SCREENING; HUMAN; LIVER; LUNG CANCER; OVARY CANCER; REGULATOR GENE; RNA PROCESSING; RNA TRANSLATION; TRANSIENT TRANSFECTION;

DISEASE; HUMANS; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SMALL MOLECULE LIBRARIES;

EID: 84883230094     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320290006     Document Type: Article

References (68)

1. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116, 281-297.
2. Bartel, D.P. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136, 215-233.
3. Pasquinelli, A.E. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat. Rev. Genet., 2012, 13, 271-282.
4. Ambros, V. microRNAs: tiny regulators with great potential. Cell, 2001, 107, 823-826.
5. He, L.; Hannon, G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet., 2004, 5, 522-531.
6. Carrington, J.C.; Ambros, V. Role of microRNAs in plant and animal development. Science, 2003, 301, 336-338.
7. Bentwich, I.; Avniel, A.; Karov, Y.; Aharonov, R.; Gilad, S.; Barad, O.; Barzilai, A.; Einat, P.; Einav, U.; Meiri, E.; Sharon, E.; Spector, Y.; Bentwich, Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet., 2005, 37, 766-770.
8. Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120, 15-20.
9. Friedman, R.C.; Farh, K.K.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19, 92-105.
10. Ebert, M.S.; Sharp, P.A. Roles for microRNAs in conferring robustness to biological processes. Cell, 2012, 149, 515-524.
11. Rottiers, V.; Naar, A.M. MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol., 2012, 13, 239-250.
12. Small, E.M.; Olson, E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature, 2011, 469, 336-342.
13. Lujambio, A.; Lowe, S.W. The microcosmos of cancer. Nature, 2012, 482, 347-355.
14. Lu, J.; Getz, G.; Miska, E.A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B.L.; Mak, R.H.; Ferrando, A.A.; Downing, J.R.; Jacks, T.; Horvitz, H.R.; Golub, T.R. MicroRNA expression profiles classify human cancers. Nature, 2005, 435, 834-838.
15. Zhang, B.; Pan, X.; Cobb, G.P.; Anderson, T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol., 2007, 302, 1-12.
16. Deiters, A. Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J., 2010, 12, 51-60.
17. Li, L.M.; Hu, Z.B.; Zhou, Z.X.; Chen, X.; Liu, F.Y.; Zhang, J.F.; Shen, H.B.; Zhang, C.Y.; Zen, K. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBVpositive hepatocarcinoma. Cancer Res., 2010, 70, 9798-9807.
18. Chen, X.; Hu, Z.; Wang, W.; Ba, Y.; Ma, L.; Zhang, C.; Wang, C.; Ren, Z.; Zhao, Y.; Wu, S.; Zhuang, R.; Zhang, Y.; Hu, H.; Liu, C.; Xu, L.; Wang, J.; Shen, H.; Zhang, J.; Zen, K.; Zhang, C.Y. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer., 2012, 130, 1620-1628.
19. Zhang, C.; Wang, C.; Chen, X.; Yang, C.; Li, K.; Wang, J.; Dai, J.; Hu, Z.; Zhou, X.; Chen, L.; Zhang, Y.; Li, Y.; Qiu, H.; Xing, J.; Liang, Z.; Ren, B.; Yang, C.; Zen, K.; Zhang, C.Y. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin. Chem., 2010, 56, 1871-1879.
20. Zen, K.; Zhang, C.Y. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med. Res. Rev., 2012, 32, 326-348.
21. Shi, X.B.; Tepper, C.G.; deVere White, R.W. Cancerous miRNAs and their regulation. Cell Cycle, 2008, 7, 1529-1538.
22. Hermeking, H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer., 2012, 12, 613-626.
23. Le, M.T.; Teh, C.; Shyh-Chang, N.; Xie, H.; Zhou, B.; Korzh, V.; Lodish, H.F.; Lim, B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev., 2009, 23, 862-876.
24. Kumar, M.; Lu, Z.; Takwi, A.A.; Chen, W.; Callander, N.S.; Ramos, K.S.; Young, K.H.; Li, Y. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene, 2011, 30, 843-853.
25. Cullen, B.R. RNAi the natural way. Nat. Genet., 2005, 37, 1163-1165.
26. Lee, Y.; Kim, M.; Han, J.; Yeom, K.H.; Lee, S.; Baek, S.H.; Kim, V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J., 2004, 23, 4051-4060.
27. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim, J.; Lee, J.; Provost, P.; Radmark, O.; Kim, S.; Kim, V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425, 415-419.
28. Lund, E.; Guttinger, S.; Calado, A.; Dahlberg, J.E.; Kutay, U. Nuclear export of microRNA precursors. Science, 2004, 303, 95-98.
29. Winter, J.; Jung, S.; Keller, S.; Gregory, R.I.; Diederichs, S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol., 2009, 11, 228-234.
30. Kim, V.N.; Han, J.; Siomi, M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol., 2009, 10, 126-139.
31. Filipowicz, W. RNAi: the nuts and bolts of the RISC machine. Cell, 2005, 122, 17-20.
32. Liu, J.; Carmell, M.A.; Rivas, F.V.; Marsden, C.G.; Thomson, J.M.; Song, J.J.; Hammond, S.M.; Joshua-Tor, L.; Hannon, G.J. Argonaute2 is the catalytic engine of mammalian RNAi. Science, 2004, 305, 1437-1441.
33. Thorsen, S.B.; Obad, S.; Jensen, N.F.; Stenvang, J.; Kauppinen, S. The therapeutic potential of microRNAs in cancer. Cancer J., 2012, 18, 275-284.
34. Connelly, C.M.; Thomas, M.; Deiters, A. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J. Biomol. Screen., 2012, 17, 822-828.
35. Chen, X.J.; Huang, C.M.; Zhang, W.J.; Wu, Y.H.; Chen, X.; Zhang, C.Y.; Zhang, Y. A universal activator of microRNAs identified from photoreaction products. Chem. Commun., 2012, 48, 6432-6434.
36. Young, D.D.; Connelly, C.M.; Grohmann, C.; Deiters, A. Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J. Am. Chem. Soc., 2010, 132, 7976-7981.
37. Shan, G.; Li, Y.; Zhang, J.; Li, W.; Szulwach, K.E.; Duan, R.; Faghihi, M.A.; Khalil, A.M.; Lu, L.; Paroo, Z.; Chan, A.W.; Shi, Z.; Liu, Q.; Wahlestedt, C.; He, C.; Jin, P. A small molecule enhances RNA interference and promotes microRNA processing. Nat. Biotechnol., 2008, 26, 933-940.
38. Gumireddy, K.; Young, D.D.; Xiong, X.; Hogenesch, J.B.; Huang, Q.; Deiters, A. Small-molecule inhibitors of microrna miR-21 function. Angew. Chem. Int. Ed., 2008, 47, 7482-7484.
39. Melo, S.; Villanueva, A.; Moutinho, C.; Davalos, V.; Spizzo, R.; Ivan, C.; Rossi, S.; Setien, F.; Casanovas, O.; Simo-Riudalbas, L.; Carmona, J.; Carrere, J.; Vidal, A.; Aytes, A.; Puertas, S.; Ropero, S.; Kalluri, R.; Croce, C.M.; Calin, G.A.; Esteller, M. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 4394-4399.
40. Watashi, K.; Yeung, M.L.; Starost, M.F.; Hosmane, R.S.; Jeang, K.T. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J. Biol. Chem., 2010, 285, 24707-24716.
41. Maiti, M.; Nauwelaerts, K.; Herdewijn, P. Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing. Bioorg. Med. Chem. Lett., 2012, 22, 1709-1711.
42. Murata, A.; Fukuzumi, T.; Umemoto, S.; Nakatani, K. Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: Targeting secondary structures of pre-miRNA by small molecules. Bioorg. Med. Chem. Lett., 2013, 23, 252-255.
43. Davies, B.P.; Arenz, C. A fluorescence probe for assaying micro RNA maturation. Bioorg. Med. Chem., 2008, 16, 49-55.
44. Klemm, C.M.; Berthelmann, A.; Neubacher, S.; Arenz, C. Short and Efficient Synthesis of Alkyne-Modified Amino Glycoside Building Blocks. Eur. J. Org. Chem., 2009, 2788-2794.
45. Chan, J.A.; Krichevsky, A.M.; Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 2005, 65, 6029-6033.
46. Bose, D.; Jayaraj, G.; Suryawanshi, H.; Agarwala, P.; Pore, S.K.; Banerjee, R.; Maiti, S. The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew. Chem. Int. Ed., 2012, 51, 1019-1023.
47. Chang, J.; Nicolas, E.; Marks, D.; Sander, C.; Lerro, A.; Buendia, M.A.; Xu, C.; Mason, W.S.; Moloshok, T.; Bort, R.; Zaret, K.S.; Taylor, J.M. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol., 2004, 1, 106-113.
48. Bai, S.; Nasser, M.W.; Wang, B.; Hsu, S.H.; Datta, J.; Kutay, H.; Yadav, A.; Nuovo, G.; Kumar, P.; Ghoshal, K. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J. Biol. Chem., 2009, 284, 32015-32027.
49. Li, J.; Ghazwani, M.; Zhang, Y.; Lu, J.; Li, J.; Fan, J.; Gandhi, C.R.; Li, S. miR-122 Regulates Collagen Production via Targeting Hepatic Stellate Cells and Suppressing P4HA1 Expression. J. Hepatol., 2012.
50. Hayes, C.N.; Akamatsu, S.; Tsuge, M.; Miki, D.; Akiyama, R.; Abe, H.; Ochi, H.; Hiraga, N.; Imamura, M.; Takahashi, S.; Aikata, H.; Kawaoka, T.; Kawakami, Y.; Ohishi, W.; Chayama, K. Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle. PLoS One, 2012, 7, e47490.
51. Fukuhara, T.; Matsuura, Y. [miR-122 participates in the cell tropism of hepatitis C virus]. Uirusu, 2012, 62, 1-8.
52. Xu, J.; Zhu, X.; Wu, L.; Yang, R.; Yang, Z.; Wang, Q.; Wu, F. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/betacatenin pathway. Liver Int., 2012, 32, 752-760.
53. Tsai, W.C.; Hsu, S.D.; Hsu, C.S.; Lai, T.C.; Chen, S.J.; Shen, R.; Huang, Y.; Chen, H.C.; Lee, C.H.; Tsai, T.F.; Hsu, M.T.; Wu, J.C.; Huang, H.D.; Shiao, M.S.; Hsiao, M.; Tsou, A.P. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest., 2012, 122, 2884-2897.
54. Khong, A.; Forestieri, R.; Williams, D.E.; Patrick, B.O.; Olmstead, A.; Svinti, V.; Schaeffer, E.; Jean, F.; Roberge, M.; Andersen, R.J.; Jan, E. A daphnane diterpenoid isolated from Wikstroemia polyantha induces an inflammatory response and modulates miRNA activity. PLoS One, 2012, 7, e39621.
55. Chandrasekhar, S.; Pushpavalli, S.N.; Chatla, S.; Mukhopadhyay, D.; Ganganna, B.; Vijeender, K.; Srihari, P.; Reddy, C.R.; Janaki Ramaiah, M.; Bhadra, U. aza-Flavanones as potent cross-species microRNA inhibitors that arrest cell cycle. Bioorg. Med. Chem. Lett., 2012, 22, 645-648.
56. Frankel, L.B.; Christoffersen, N.R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 2008, 283, 1026-1033.
57. Suzuki, C.; Garces, R.G.; Edmonds, K.A.; Hiller, S.; Hyberts, S.G.; Marintchev, A.; Wagner, G. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 3274-3279.
58. Lanford, R.E.; Hildebrandt-Eriksen, E.S.; Petri, A.; Persson, R.; Lindow, M.; Munk, M.E.; Kauppinen, S.; Orum, H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science, 2010, 327, 198-201.
59. Norman, K.L.; Sarnow, P. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J. Virol., 2010, 84, 666-670.
60. Lin, C.J.; Gong, H.Y.; Tseng, H.C.; Wang, W.L.; Wu, J.L. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun., 2008, 375, 315-320.
61. Mudhasani, R.; Zhu, Z.; Hutvagner, G.; Eischen, C.M.; Lyle, S.; Hall, L.L.; Lawrence, J.B.; Imbalzano, A.N.; Jones, S.N. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. J. Cell Biol., 2008, 181, 1055-1063.
62. Chiosea, S.; Jelezcova, E.; Chandran, U.; Acquafondata, M.; McHale, T.; Sobol, R.W.; Dhir, R. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol., 2006, 169, 1812-1820.
63. Yeung, M.L.; Yasunaga, J.; Bennasser, Y.; Dusetti, N.; Harris, D.; Ahmad, N.; Matsuoka, M.; Jeang, K.T. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human Tcell lymphotrophic virus 1. Cancer Res., 2008, 68, 8976-8985.
64. Shenouda, S.K.; Alahari, S.K. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev., 2009, 28, 369-378.
65. Gushwa, N.N.; Kang, S.; Chen, J.; Taunton, J. Selective Targeting of Distinct Active Site Nucleophiles by Irreversible Src-Family Kinase Inhibitors. J. Am. Chem. Soc., 2012, 134, 20214-20217.
66. Chauvigne-Hines, L.M.; Anderson, L.N.; Weaver, H.M.; Brown, J.N.; Koech, P.K.; Nicora, C.D.; Hofstad, B.A.; Smith, R.D.; Wilkins, M.J.; Callister, S.J.; Wright, A.T. Suite of Activity-Based Probes for Cellulose-Degrading Enzymes. J. Am. Chem. Soc., 2012, 134, 20521-20532.
67. Nicolas, J.; Mura, S.; Brambilla, D.; Mackiewicz, N.; Couvreur, P. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev., 2012, 42, 1147-1235.
68. Ensign, L.M.; Schneider, C.; Suk, J.S.; Cone, R.; Hanes, J. Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv. Mater., 2012, 24, 3887-3894.